Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
What keeps you up at night in ophthalmology: Part II
Pharmaceutical representatives share what keeps them up at night within the ophthalmic space.
In this second video installment, pharmaceutical representatives share what keeps them up at night within the ophthalmic and glaucoma space while attending the 2020 Glaucoma 360 meeting in San Francisco, California.
Featured: Chris Adams, Diopter Corp (CEO); Daria Lemann-Blumenthal, BELKIN Laser Ltd (CEO); Victor Chan, MB, MS, director of U.S. Surgical Device Commercial Marketing (Santen, Inc); Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline (Allergan).
Related Videos
Related Content
